findmyKOL

Lawrence Young, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI
RegionNew Haven, CT · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPaymentsNone reportedNIH funding1985–2024Why? →

Lawrence Young is a Cardiology physician.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
7NIH grants · 1985–2024

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

789 Howard Ave
Dana Building, 3rd Fl
New Haven, CT 065191304

Telephone

203-785-4629

Registry record last updated 7 Apr 2011.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    85.4%
    Beta blocker26.5%
    Metoprolol Succinate70%Metoprolol Tartrate10%Carvedilol9%Sotalol8%Labetalol Hcl4%
    Part D<11 patients
    Statin21%
    Atorvastatin Calcium49%Rosuvastatin Calcium42%Simvastatin10%
    Part D<11 patients

    + 9 more classes in this area

  • Blood & clotting

    10.3%
    Factor Xa inhibitor8.8%
    Eliquis81%Xarelto19%
    Part D<11 patients
    P2Y12 inhibitor1.4%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    4.3%
    SGLT2 inhibitor2.6%
    Farxiga100%
    Part D11 patients
    Potassium supplement1.7%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)74.9% facility · 25.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

7 NIH research awards on record, funded 19852024 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”